國立高雄大學圖資館 |

Language: English

Back

Targeting oncogenic driver mutations in lung cancer

Record Type:	Electronic resources : Monograph/item
Title/Author:	Targeting oncogenic driver mutations in lung cancerMatthew Lee ... [et al.].
other author:	Lee, Matthew Allen,
Published:	Cambridge :Cambridge University Press,2023.
Description:	87 p. :ill., digital ;23 cm.
Notes:	Also issued in print: 2023.
Subject:	LungsCancer
Online resource:	https://doi.org/10.1017/9781009336123
ISBN:	9781009336123

Targeting oncogenic driver mutations in lung cancer
Targeting oncogenic driver mutations in lung cancer[electronic resource] /Matthew Lee ... [et al.]. - Cambridge :Cambridge University Press,2023. - 87 p. :ill., digital ;23 cm. - Cambridge elements. Elements in molecular oncology. - Cambridge elements.Elements in molecular oncology..

Also issued in print: 2023.

Includes bibliographical references.

The recent advances in the field of molecular diagnostic techniques have led to the identification of targetable alterations prompting a paradigm shift in the management of non-small cell lung cancer (NSCLC) and an era of precision oncology. This text highlights the most clinically relevant oncogenic drivers other than EGFR, their management and current advancements in treatment. It also examines the different challenges in resistance to targeted therapies and diagnostic dilemmas for each oncogenic driver and the future direction of NSCLC management.

Specialized.

ISBN: 9781009336123

Standard No.: 10.1017/9781009336123doiSubjects--Topical Terms:

531376
Lungs
--Cancer

LC Class. No.: RC280.L8 / L4 2023

Dewey Class. No.: 616.99424

National Library of Medicine Call No.: WF 658

Targeting oncogenic driver mutations in lung cancer
LDR:01671nmm a2200325 a 4500 001 662013
003 StDuBDS
005 20230131124228.0
006 m d
007 cr nn 008maaau
008 241120s2023 enka fob 000 0 eng d
020 $a 9781009336123 $q (electronic bk.)
020 $a 9781009336130 $q (paperback)
024 7 $a 10.1017/9781009336123 $2 doi
035 $a CR9781009336123
040 $a StDuBDS $b eng $c StDuBDS $d GP
041 0 $a eng
050 4 $a RC280.L8 $b L4 2023
060 4 $a WF 658
082 0 4 $a 616.99424 $2 23
090 $a RC280.L8 $b L479 2023
245 0 0 $a Targeting oncogenic driver mutations in lung cancer $h [electronic resource] / $c Matthew Lee ... [et al.].
260 $a Cambridge : $b Cambridge University Press, $c 2023.
300 $a 87 p. : $b ill., digital ; $c 23 cm.
490 1 $a Cambridge elements. Elements in molecular oncology
500 $a Also issued in print: 2023.
504 $a Includes bibliographical references.
520 8 $a The recent advances in the field of molecular diagnostic techniques have led to the identification of targetable alterations prompting a paradigm shift in the management of non-small cell lung cancer (NSCLC) and an era of precision oncology. This text highlights the most clinically relevant oncogenic drivers other than EGFR, their management and current advancements in treatment. It also examines the different challenges in resistance to targeted therapies and diagnostic dilemmas for each oncogenic driver and the future direction of NSCLC management.
521 $a Specialized.
588 $a Description based on online resource; title from PDF title page (viewed on January 26, 2023).
650 0 $a Lungs $x Cancer $x Treatment. $3 531376
650 0 $a Cancer $x Molecular aspects. $3 221221
700 1 $a Lee, Matthew Allen, $d 1980- $3 973619
830 0 $a Cambridge elements. $p Elements in molecular oncology. $3 973620
856 4 0 $u https://doi.org/10.1017/9781009336123